1 – 19 of 19
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Comparison Between Ticagrelor and Clopidogrel in Elderly Patients With an Acute Coronary Syndrome : Insights From the SWEDEHEART Registry
(
- Contribution to journal › Article
- 2019
-
Mark
Cangrelor for ST-Segment-Elevation Myocardial Infarction
(
- Contribution to journal › Debate/Note/Editorial
- 2017
-
Mark
The Rationale for and Clinical Pharmacology of Prasugrel 5 mg
(
- Contribution to journal › Article
- 2015
-
Mark
Differences in the profile of protection afforded by TRO40303 and mild hypothermia in models of cardiac ischemia/reperfusion injury.
(
- Contribution to journal › Article
- 2008
-
Mark
Primary and secondary capture of platelets onto inflamed femoral artery endothelium is dependent on P-selectin and PSGL-1.
(
- Contribution to journal › Article
- 2003
-
Mark
The stable pyrimidines UDPbetaS and UTPgammaS discriminate between contractile cerebrovascular P2 receptors.
(
- Contribution to journal › Article
-
Mark
Extracellular nucleotides induce vasodilatation in human arteries via prostaglandins, nitric oxide and endothelium-derived hyperpolarising factor.
(
- Contribution to journal › Article
- 2000
-
Mark
P2Y receptors contribute to ATP-induced increases in intracellular calcium in differentiated but not undifferentiated PC12 cells
(
- Contribution to journal › Article
-
Mark
The stable pyrimidines UDPbetaS and UTPgammaS discriminate between the P2 receptors that mediate vascular contraction and relaxation of the rat mesenteric artery
(
- Contribution to journal › Article
-
Mark
P2X receptors counteract the vasodilatory effects of endothelium derived hyperpolarising factor
(
- Contribution to journal › Article
- 1999
-
Mark
Endothelial P2Y receptors induce hyperpolarisation of vascular smooth muscle by release of endothelium-derived hyperpolarising factor
(
- Contribution to journal › Article
- 1998
-
Mark
P2U-receptor mediated endothelium-dependent but nitric oxide-independent vascular relaxation
(
- Contribution to journal › Article
- 1997
-
Mark
In vivo receptor characterization of neuropeptide Y-induced effects in consecutive vascular sections of cat skeletal muscle
(
- Contribution to journal › Article
- 1996
-
Mark
Neuropeptide Y potentiates noradrenaline-induced contraction through the neuropeptide Y Y1 receptor
(
- Contribution to journal › Article
-
Mark
Tyrphostin inhibition of ATP-stimulated DNA synthesis, cell proliferation and fos-protein expression in vascular smooth muscle cells
(
- Contribution to journal › Article
-
Mark
Effects of phosphorothioated neuropeptide Y Y1-receptor antisense oligodeoxynucleotide in conscious rats and in human vessels
(
- Contribution to journal › Article
- 1995
-
Mark
Characterisation of an ATP receptor mediating mitogenesis in vascular smooth muscle cells
(
- Contribution to journal › Article
- 1994
-
Mark
Human endothelin ETA receptor antisense oligodeoxynucleotides inhibit endothelin-1 evoked vasoconstriction
(
- Contribution to journal › Article
- 1993
-
Mark
Human neuropeptide Y Y1 receptor antisense oligodeoxynucleotide specifically inhibits neuropeptide Y-evoked vasoconstriction
(
- Contribution to journal › Article